Insights from SARS-CoV-2 nanopore genomic surveillance in Edo State, Nigeria
Abstract In response to the COVID-19 pandemic, local SARS-CoV-2 nanopore sequencing capacity was established at Irrua Specialist Teaching Hospital (ISTH), a Lassa fever reference centre based in Edo State, Nigeria. This was enabled through training of local staff in Nigeria and Guinea in both laboratory and bioinformatic SARS-CoV-2 sequencing protocols. Between March 2020 and December 2023, the laboratory at ISTH conducted 29,643 diagnostic tests for SARS-CoV-2, of which 4,575 (15.4%) were positive. Between April and December 2022, 410 SARS-CoV-2 positive samples were selected and retrospectively sequenced in 19 runs. From these, 213 near-complete (> 93%) viral genomes were generated and submitted to GISAID. Phylogenetic and phylogeographic analyses supported that Nigeria served simultaneously as a source and recipient of SARS-CoV-2 lineages, driving global spread of the AY.36 Delta variant and receiving Omicron sublineages (BA.1.1 and BQ.1) from North America and Europe. Here we show that a pre-existing long-term laboratory capacity development program for Lassa virus, a high-risk pathogen, facilitated the successful integration of novel workflows for a new emerging pathogen.
Authors
- Fara Raymond Koundouno
- Ikponmwosa Odia (ORCID: https://orcid.org/0000-0002-9393-9898)
- N’Faly Magassouba (ORCID: https://orcid.org/0000-0002-3760-6642)
- Sylvanus Akhalufo Okogbenin (ORCID: https://orcid.org/0000-0001-7882-8316)
- Annick Renevey (ORCID: https://orcid.org/0000-0001-7411-6063)
- Lisa Oestereich (ORCID: https://orcid.org/0000-0003-0098-7485)
- Mette Hinrichs (ORCID: https://orcid.org/0009-0000-4371-5768)
- Joseph Okoeguale (ORCID: https://orcid.org/0009-0008-9909-4700)
- Emanuele Gustani‐Buss (ORCID: https://orcid.org/0000-0003-4020-3921)
- Cyril Oshomah Erameh (ORCID: https://orcid.org/0000-0001-7783-2495)
- Jacob Camara (ORCID: https://orcid.org/0000-0003-4837-0206)
- Sarah Ryter (ORCID: https://orcid.org/0000-0003-1597-9656)
- Sophie Duraffour (ORCID: https://orcid.org/0000-0002-1239-4372)
- Ephraim Ogbaini-Emovon (ORCID: https://orcid.org/0000-0001-5407-1152)
- Julia Hinzmann
- Ganiyu Igenegbale
- Emily Victoria Nelson (ORCID: https://orcid.org/0000-0002-4502-4861)
- Stephan Günther (ORCID: https://orcid.org/0000-0002-6562-0230)
- Kékoura Ifono
- Giuditta Annibaldis (ORCID: https://orcid.org/0009-0007-1570-4624)
- Beate Becker‐Ziaja (ORCID: https://orcid.org/0009-0004-8245-9049)
- Meike Pahlmann (ORCID: https://orcid.org/0000-0001-8423-4178)
- Sanaba Boumbaly (ORCID: https://orcid.org/0000-0002-4506-6033)
- Liana Eleni Kafetzopoulou (ORCID: https://orcid.org/0000-0003-4531-1374)
- Alexandru Tomazatos (ORCID: https://orcid.org/0009-0006-8771-5579)
- Reuben Agbons Eifediyi (ORCID: https://orcid.org/0009-0007-7877-3045)
- Donatus Itsoghiaonode Adomeh
- Ehizojie Emua (ORCID: https://orcid.org/0009-0004-9968-0815)
- Racheal Omiunu
- Christine Jacobsen (ORCID: https://orcid.org/0009-0001-0169-5364)
- Precious Olachukwu Njigha
- Obehiaghe Benedicta Okogbenin
- Paulson Ehichioya Ebhodaghe
Institutions
- Irrua Specialist Teaching Hospital (NG)
- Bernhard Nocht Institute for Tropical Medicine (DE)
- KU Leuven (BE)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11465448/v1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- preprint
Funders
- European Commission
- Bundesministerium für Gesundheit
- Vlaamse regering
- Horizon 2020 Framework Programme